Objective: A systematic review and meta-analysis of randomized controlled trials (RCTs) studying the clinical benefit of chemotherapy with surgical intervention over chemotherapy alone for the treatment of spinal tuberculosis. Methods: Relevant RCTs were identified by computerized database searches. Trial eligibility and methodological quality were assessed and data were extracted and analysed using odds ratios with 95% confidence intervals. The primary outcome measure was kyphosis angle. Results: The literature search identified two RCTs conducted in the 1970s and 1980s and a Cochrane Database Systematic Review published in 2006. There were no significant betweengroup differences in kyphosis angle, bony fusion, bone loss or development of neurological deficit. Conclusions: There is no obvious statistically significant clinical precedence to suggest that routine surgery will improve the prognosis of patients with spinal tuberculosis.
Introduction
Spinal tuberculosis (TB) or Pott disease was first reported in 1779 and represents <1% of all TB cases. [1] [2] [3] Given the increasing prevalence of TB worldwide, spinal TB is a significant healthcare issue, 4 with the incidence of neurological complications varying between 10% and 43%. 1 The standard management protocol for spinal TB is isoniazid, rifampicin and pyrazinamide chemotherapy for a minimum of 6 months. [5] [6] [7] In addition, debridement of diseased tissues is routinely performed via an anterolateral extrapleural approach, [8] [9] [10] [11] transpleural anterior approach 8, 12, 13 or posterior spinal fusion. 14, 15 Pre-and postsurgical debridement chemotherapy is commonly employed. 16 A review article suggested that surgery in spinal TB is an incidental decision, with no established protocol for the decision-making process and few randomized controlled trials regarding indications for surgery. 17 Surgical intervention decisions are based on: (i) patient age; (ii) presence of comorbidities; (iii) location of bony loss; (iv) relative position of the compressive lesion with regard to the dura, and density of the compressive lesion; (v) number of segments involved; (vi) kyphosis angle; and (vii) region of focal infection, 17, 18 with the major contraindications being high cost and risk of postoperative complications. 17 It is imperative to perform surgery only if the outcome will be more beneficial than treatment with chemotherapy alone. The objective of the current review of randomized controlled trials was to compare the outcome of chemotherapy alone or a combination of surgery and chemotherapy in patients with spinal TB. 
Materials and methods

Data sources and searches
Assessment of methodological quality
Eligibility assessment and data extraction were both performed independently in an unblended standardized manner by two independent reviewers (X.Z. and B.L.) according to Critical Appraisal Skills Programme (CASP) guidelines. 19 The inclusion of all randomized participants in the final analysis was evaluated and at least 60% completeness of follow-up at each time point was fixed as the threshold. The physicians treating the patients were not blinded either during treatment or follow-up. Scars were visible on X-radiographs of patients included in the studies used in the metaanalysis.
Data extraction, synthesis and analysis
The results of all searches were combined and duplicate articles were removed. Inclusion criteria were: (i) 1 year followup after initiation of treatment regimen; (ii) confirmed diagnosis of active TB of the thoracic and/or lumbar spine, including the upper sacral vertebra S1; (iii) diagnosis based on X-radiographs showing loss of thin cortical outline and rarefaction of the affected vertebral bodies; (iv) intervention was chemotherapy alone or chemotherapy plus surgery.
Statistical analyses
The outcomes (kyphosis angle, bone loss, bony formation and neurological deficit) of the collected manuscripts were synthesized in piloted forms independently and in duplicate (X.Z. and B.L.) and formed the basis for meta-analysis, which was performed according to Cochrane Collaboration and the Quality of Reporting of Meta-analyses (QUORUM) guidelines. 20 Odds ratios (OR) were used to analyse all dichotomous outcome measures, and data were presented with 95% confidence intervals (CI). The risk of bias of each relevant article was assessed using the 12 criteria recommended by the Cochrane Back Review Group. 19 Criteria were scored 'yes' (criterion met), 'no' (criterion not met) or 'unsure' (not enough information to make the decision). Articles that met six of the 12 criteria were considered to have a low risk of bias. Potential publication bias was tested using a funnel plot. Data were compared using 2 -test. Statistical analyses were performed using SPSS Õ version 18.0 (SPSS Inc., Chicago, IL, USA) for Windows Õ . P-values <0.05 were considered to be statistically significant.
Results
The literature search identified 35 potentially relevant articles, of which 28 16, were excluded (Table 1, Figure 1 ). In addition, a systematic review published in 2006 was identified, 17 which analysed seven papers reporting on two randomized controlled trials (total n ¼ 331) ( Table 2 ). [48] [49] [50] [51] [52] [53] [54] Both trials were initiated by the British Medical Research Council (MRC) Working Party on Tuberculosis of the Spine, with one performed in cooperation with the Indian Council of Medical Research (ICMR). These trials formed the basis of the current analysis.
The characteristics of the study participants are summarized in Table 3 . The methods used to generate allocation sequences were unclear in both trials, but allocation concealment was adequate. Completeness of follow up in the MRC 1974 trial 48, 49 was adequate after 3 and 5 years (72% and 62%, respectively). In the ICMR/MRC 1989 trial, [50] [51] [52] [53] [54] follow-up was adequate at 3, 5 and 10 years (83%, 82% and 78%, respectively). Analysis in the both trials was by intention to treat.
Kyphosis angle was a primary outcome measure in both trials. The mean kyphosis angle was reported to be within the same range at 18 months and at 3, 5 and 10 years ( Table 4 ), but it was not possible to assess statistical significance in the present analysis as standard deviations were not provided. Deterioration in kyphosis angle >10 at 5 years had an OR of 1.02 (95% CI 0.41, 2.55) and 1.17 (95% CI 0.41, 3.29) in the ICMR/MRC 1989 and MRC 1974 studies, respectively. In ICMR/MRC 1989 at 10 years follow-up, a baseline kyphosis angle of >30 deteriorated (increased) with a mean of 10-30 . [48] [49] [50] [51] [52] A subgroup effect was reported in the chemotherapy group of the ICMR 1989 trial, where patients aged <15 years (initial angle >30 ) had a mean deterioration of 30 compared with patients aged >15 years (initial angle >30 ) who deteriorated with a mean of 10 (P ¼ 0.001). 51, 53, 54 There were no statistically significant between-group differences in the number of patients with >10 deterioration at 3 years (n ¼ 78, 1 trial) or 5 years (n ¼ 144, 2 trials). [50] [51] [52] [53] [54] Both trials reported on the neurological status of the participants. No participants who were free from neurological deficit on entry developed any deficit, and there were no statistically significant changes over time in the numbers of patients with neurological deficit (n ¼ 23 at entry, n ¼ 23 at 18 months, n ¼ 23 at 3 years and 20 at 5 years). [48] [49] [50] [51] [52] [53] [54] There was no statistically significant difference between the intervention and control at 18 months (n ¼ 261, two trials), 3 years (n ¼ 262, two trials), 5 years (n ¼ 244, two trials) and 10 years (n ¼ 156, one trial). [48] [49] [50] [51] [52] [53] [54] There was no statistically significant difference between chemotherapy plus surgery and chemotherapy alone on the presence of bone loss at 18 months (n ¼ 256, two trials), 3 years (n ¼ 247, two trials), 5 years (n ¼ 236, two trials), or 10 years (n ¼ 156, one trial) ( Table 5 ). [48] [49] [50] [51] [52] [53] [54] It was not possible to assess the statistical significance of data regarding bone loss due to the absence of standard deviations; however, the majority of bone loss (vertebral destruction) was present at the time of diagnosis with limited further destruction occurring during treatment and the subsequent follow-up period. [48] [49] [50] [51] [52] [53] [54] Publication bias within the studies were assessed both visually, using a funnel plot (Figure 2) , as well as the 12 criteria recommended by the Cochrane Back Review Group 19 (Figure 3 ). There was no evidence of publication bias on the funnel plot, and the number of criteria met was 9/12 in both studies. All of the studies included in the current meta-analyses were thus considered to have a negligible risk of bias. None of the included studies had an adequate description of withdrawals or drop outs (Figure 3 ). 22 Not randomized Fu et al. 2009 16 Not randomized Park et al. 2007 23 Not randomized Wang et al. 2007 24 Not randomized Sai Kiran et al. 2007 25 Not randomized Chadha et al. 2007 26 Not randomized Kotil et al. 2007 27 Not randomized Jain et al. 2004 28 Not randomized Loembe 1994 29 Not randomized MRC 1973 30 No surgical group MRC 1973 31 No surgical group MRC 1974 32 All participants had surgery MRC 1976 33 No surgical group MRC 1978 34 All participants had surgery MRC 1982 35 All participants had surgery MRC 1985 36 No surgical group MRC 1986 37 All participants had surgery MRC 1993 38 No surgical group MRC 1998 39 No randomization for conservative or surgical treatment; two locations, Korea (all chemotherapy without surgery) and Hong Kong (all chemotherapy plus surgery) Rajasekaran et al. 1998 40 No surgical group Rajeswari et al. 1997 41 Not a randomized controlled trial, poor methodological quality, randomization method and concealment unclear Seddon 1976 42 Description of several MRC studies, not a study itself Upadhyay et al. 1993 43 All participants had surgery Upadhyay et al. 1994 44 All participants had surgery Upadhyay et al. 1994 45 All participants had surgery Upadhyay et al. 1994 46 All participants had surgery Upadhyay et al. 1996 47 All participants had surgery ICMR, Indian Council of Medical Research; MRC, Medical Research Council.
Discussion
The objective of this systematic review and meta-analysis was to compare chemotherapy plus surgery with chemotherapy alone for treatment of spinal TB. There was no statistically significant benefit of routine surgery, and surgery had no effect on kyphosis angle. The incidence of progressive kyphosis and the kyphosis angle at study entry were high (>30 ) for all participants. [48] [49] [50] [51] [52] [53] [54] Spinal surgeons generally consider kyphosis >30 to be unacceptably high and an indication for surgical correction. 18 The current review revealed no betweengroup difference in bony fusion, which is often considered the best evidence of healing. 46, 47 Data on the speed of bony fusion were not provided in either trial, and it was therefore not possible to assess differences 
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Location of lesions T1-S1 T1-S1 T1- L2  T1-L2  Kyphosis angle,  entry  27  24  29  29  18 months  40  30  41  41  3 years  40  32  41  42  5 years  39  30  37  40  10 years  --41  47 (continued) Figure 2 . Funnel plot of studies included in the current meta-analysis of randomized controlled trials comparing chemotherapy and chemotherapy plus surgery for treatment of spinal tuberculosis. There was no evidence of publication bias. during early phases of treatment. The amount of bone is considered important for the stability of the spine; as both studies excluded patients with >3 U total bone loss, the role of surgery in these more severe cases could not be assessed. A small number of participants had neurological deficit at study entry, but there were no statistically significant between-group differences in the improvement of this deficit. Deterioration of neurological deficit or persisting deficit with spinal cord compression can be an indication for surgery, 17 and a small group of patients (n ¼ 5/130) in the chemotherapy group required surgery to decompress the spinal cord. [48] [49] [50] [51] [52] The current analysis has several limitations, the most important of which is the availability of only two relevant studies, severely restricting the value of the metaanalysis findings. In addition, there was inadequate follow-up data for the MRC trial 48, 49 at any time point, and at 10 years in the ICMR/MRC trial. [50] [51] [52] [53] [54] Finally, both trials were performed almost three decades ago and their current clinical relevance is difficult to determine given the advances in medical and surgical management of spinal TB. It is therefore imperative that randomized controlled trials are initiated to assess the benefits of surgery in spinal TB in the current setting. Several small-scale non-randomized studies Figure 3 . Overall quality of the evidence for each outcome in studies included in the current meta-analysis of randomized controlled trials comparing chemotherapy and chemotherapy plus surgery for treatment of spinal tuberculosis (MRC 1974 48, 49 and ICMR/MRC 1989 [50] [51] [52] [53] [54] ). Quality was assessed using an adapted GRADE approach, as recommended by the Cochrane Back Review Group. 19 The quality of the evidence for a specific outcome was based on the study design, risk of bias, consistency of results, directness (generalizability), precision (sufficient data) and potential bias for the reporting of results across all studies that measured that particular outcome. ITT, intention to treat.
have been performed more recently, but the results of the present analysis suggest that routine surgery cannot be recommended unless within the context of a large, well conducted randomized controlled trial.
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